Observational Study to Develop a Predictive Score for Adverse Events Post ERCP

Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Jan 14, 2025

Keywords

ClinConnect Summary

This clinical trial is looking to understand the risks of complications that can happen after a specific medical procedure called Endoscopic Retrograde Cholangiopancreatography (ERCP). This procedure is used to treat issues related to the liver, bile ducts, or pancreas. The main goal of the study is to find out what factors might increase the chances of experiencing problems after the procedure and to create a tool that can help predict these risks. Researchers will also check how often these complications occur in different healthcare centers.

If you're an adult over 18 years old and are being treated for a liver, bile, or pancreas condition that requires ERCP, you may be eligible to participate in this study. There are no specific exclusions, so most patients who meet the age and condition criteria can join. As a participant, you'll help researchers gather important information that could lead to better predictions of post-ERCP complications, which may ultimately improve patient care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age \>18 years
• • Patients admitted with hepato-biliary-pancreatic disease or other pathological conditions that require treatment by ERCP
• • Obtaining informed consent
• Exclusion Criteria:
• • None